Cognitive & Neuroprotective Khavinson Bioregulator

Pinealon

Also known as: Peptídeo cerebral

Molecular Identifiers

Molecular Formula

C15H26N6O8

CAS Number

175175-23-2

PubChem CID

10273502

Molecular Weight

418.40 Da

Overview

Cerebral bioregulatory tripeptide developed by the Khavinson group. Modulates gene expression in brain tissue, with neuroprotective properties and circadian rhythm support. Used in short, repeated cycles.

The main interest around Pinealon is neurological support — neuroprotection against oxidative stress, circadian rhythm modulation, and support for endogenous melatonin synthesis by the pineal gland. It is used in anti-aging contexts and for mild cognitive decline, cognitive function under stress, or age-related sleep disturbances.

It has no drug approval from the FDA, EMA, or ANVISA. It circulates through compounding pharmacies and bioregulatory medicine channels, in short cycles of 10-30 days repeated periodically, often combined with Epithalon in longitudinal protocols. It is also available in oral capsules in some formulations.

It belongs to the line of short tri- and tetrapeptides developed by the group of Russian researcher Vladimir Khavinson, derived from brain tissue extracts. The evidence base is predominantly Russian, with modern human clinical trials still limited.

Within the Khavinson family, Pinealon (the Glu-Asp-Arg tripeptide) sits in the pineal/cognitive subgroup with Epithalon and N-Acetyl-Epithalon: Epithalon is the classical pineal tetrapeptide focused on telomeres and anti-aging, N-Acetyl-Epithalon is its acetylated variant with proposed oral bioavailability, and Pinealon is presented more as a cerebral neuroprotector for short cyclic use. All of this comparative literature is largely Russian and preclinical.

Sequence (1 letter): EDR
Extended notation: Glu-Asp-Arg

Half-life

~2-4 hours

Administration Route

Subcutaneous or intramuscular

Category

Cognitive & Neuroprotective

Mechanism of Action

  • Modulation of gene expression in brain tissues
  • Neuroprotection against oxidative stress and neurotoxicity
  • Support for circadian rhythm regulation
  • Normalization of melatonin synthesis by the pineal gland
  • Peptide bioregulatory effect on the central nervous system

Dosage Protocol

Data compiled from the literature. This does not constitute medical advice.

Parameter Value
Dose 1-2 capsules orally (0.2 g per capsule, containing AKS-5 peptide complex)
Frequency 1-2 times daily, with meals
Timing With meals
Duration 10-30 days per cycle, repeat the course every 4-6 months

Reported Side Effects

Adverse effects described in the literature. Severity and frequency vary between individuals.

  • Mild drowsiness
  • Injection site pain (rare)

Product Properties

Purity >95%
Appearance White lyophilized powder
Solubility Soluble in water and bacteriostatic water
Source Solid-phase peptide synthesis (SPPS)
Storage Lyophilized: -20°C for up to 2 years, 2-8°C for up to 6 months. Reconstituted: 2-8°C for up to 4 weeks. Very stable tripeptide. Protect from light and moisture.

Presentations & Preparation

Vials of Pinealon found in the research market:

5 mg10 mg20 mg

Reconstitution

  • Diluent: Bacteriostatic water
  • Volume: 2 ml per vial
  • Slowly inject the diluent against the vial wall
  • Gently swirl until fully dissolved
  • Never shake
  • Also available in oral capsules

Storage

  • Lyophilized: Refrigerated 2-8°C
  • Reconstituted: Refrigerated 2-8°C (up to 30 days)
  • Protect from direct light
  • Do not freeze after reconstitution
Reconstitution Calculator

Scientific Studies

Published studies on Pinealon.

Related Peptides